QUESTIONS| Event Date/Time: Nov 01, 2012 | End Date/Time: Nov 02, 2012 |
Report as SpamDescription
In the bioreactors market, disposables are one of the fastest growing sectors with the potential for many new breakthroughs and applications in the coming years. They are an attractive alternative to the traditional large inflexible stainless steel bioreactors which require substantial capital expenditure. The industry as a whole is experiencing an increased demand for biologics which requires the use of bioreactors to cultivate specific cell lines. The number of clinical monoclonal antibodies (mAbs) in development is increasing and pharmaceutical companies are looking at developing a diverse pipeline of mAbs to fill several smaller niches and meet the demand for personalised medicine rather than large scale production of blockbusters. This has resulted in the industry demanding smaller batch sizes, quicker turnover rates and cheaper production costs as budgets are restrained.
Disposable bioreactors help fill this need as they are fast, flexible and cheap allowing for quick experimental runs of new biologics and a scalable platform to a substantial size of up to 2000 litres. They are pre-sterilised, thus removing the need for strict sterilisation and validation procedures. This process will play an important role for the manufacturing of cheap biosimilars in emerging markets due to a lack of legacy infrastructure and low capital costs. The total market will increase to approximately $59.1m by 2021, providing ample opportunity for growth.
Visiongain’s Single-Use Bioreactors conference will be the only Single-Use Bioreactors conference of its kind. This event will provide a unique networking event to boost your understanding of how to:
- Manage multiple pipelines for niche biotherapeutic products
- Analyse case studies examining ROI and cost/benefit potential
- Explore environmentally friendly methods of disposal
- Manage a diverse supply chain and increase speed of R&D turnaround
- Find the right solutions to manage bench to full scale production
- Expand production in rapidly growing BRIC economies with fast implementation and low capital costs
- Discuss the creation of standardised connectivity across the industry
- Improve downstream processing efficiency and increase capacity
Disposable bioreactors help fill this need as they are fast, flexible and cheap allowing for quick experimental runs of new biologics and a scalable platform to a substantial size of up to 2000 litres. They are pre-sterilised, thus removing the need for strict sterilisation and validation procedures. This process will play an important role for the manufacturing of cheap biosimilars in emerging markets due to a lack of legacy infrastructure and low capital costs. The total market will increase to approximately $59.1m by 2021, providing ample opportunity for growth.
Visiongain’s Single-Use Bioreactors conference will be the only Single-Use Bioreactors conference of its kind. This event will provide a unique networking event to boost your understanding of how to:
- Manage multiple pipelines for niche biotherapeutic products
- Analyse case studies examining ROI and cost/benefit potential
- Explore environmentally friendly methods of disposal
- Manage a diverse supply chain and increase speed of R&D turnaround
- Find the right solutions to manage bench to full scale production
- Expand production in rapidly growing BRIC economies with fast implementation and low capital costs
- Discuss the creation of standardised connectivity across the industry
- Improve downstream processing efficiency and increase capacity
